Company Filing History:
Years Active: 2005
Title: The Innovations of Stephane Brezillion
Introduction
Stephane Brezillion is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of G protein-coupled receptors. His work has implications for drug discovery and therapeutic applications.
Latest Patents
Brezillion holds a patent titled "Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)." This invention relates to a recombinant cell that expresses a nucleotide sequence encoding a G protein-coupled receptor. The receptor has an amino acid sequence that presents more than 70% sequence identity with SEQ ID.NO.1. The patent also includes a drug screening method and kit that utilizes the orphan G protein-coupled receptor GPR86, identified as a receptor for ADP (P2Y). This invention aims to identify agonist, inverse agonist, and antagonist compounds that can be used for the diagnosis, prevention, and treatment of various diseases and disorders.
Career Highlights
Stephane Brezillion is associated with Euroscreen S.A., a company that specializes in drug discovery and development. His work at Euroscreen has allowed him to focus on innovative approaches to understanding receptor biology and its applications in medicine.
Collaborations
Brezillion has collaborated with notable colleagues such as Didier Communi and Nathalie Suarez. These collaborations have further enhanced his research and contributed to advancements in the field.
Conclusion
Stephane Brezillion's contributions to the field of biotechnology, particularly through his patent on G protein-coupled receptors, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic strategies.